DCM
AMPE

DAFNA Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

DAFNA Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-500
Closed -$530K – 69
2014
Q3 		$530K Sell
500
-4,170
-89% -$7.02M 0.53% 36
2014
Q2 		$11.7M Sell
4,670
-749
-14% -$1.53M 11.09% 1
2014
Q1 		$10.3M Buy
5,419
+4,000
+282% +$9.46M 8.87% 4
2013
Q4 		$3.04M Hold
1,419
– – 3.12% 11
2013
Q3 		$3.19M Buy
+1,419
New +$2.74M 3.49% 10

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DAFNA Capital Management's AMPE Position: Q4 2014 in Review

DAFNA Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2014, closing a stake of 500 shares — an estimated $530K sold.

DAFNA Capital Management first reported a position in AMPE in Q3 2013 and held it in 5 quarters. The position peaked at $11.7M in Q2 2014. 69 funds tracked by Wall St. Rank hold AMPE as of Q4 2014.

  • DAFNA Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2014 after selling out during the quarter.
  • DAFNA Capital Management sold 500 Ampio Pharmaceuticals Inc. shares in Q4 2014, an estimated $530K.
  • DAFNA Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 5 quarters.
  • DAFNA Capital Management's Ampio Pharmaceuticals Inc. position peaked at $11.7M in Q2 2014.
  • 69 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2014.

Based on DAFNA Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.